BRILINTA 90 MG AstraZeneca

• BRILINTA is a prescription medication.
• It is manufactured by AstraZeneca.
• Primarily used for patients with certain heart conditions.
• Contains the active ingredient ticagrelor.
• May have implications for athletic performance.

About BRILINTA 90 MG AstraZeneca, chemical structure and characteristics

BRILINTA, which is chemically known as ticagrelor, is an antiplatelet medication used to prevent cardiovascular events such as heart attacks and strokes. Its unique mechanism of action involves reversibly binding to the ADP receptors on platelets, thereby inhibiting platelet aggregation. This interferes with the stimulation of the GPIIb/IIIa receptor and decreases thrombus formation. The chemical structure of ticagrelor allows it to have a rapid onset of action and efficient absorption, making it a vital therapeutic option for patients at high risk of atherothrombotic events.

Also notable is its bioavailability. Approximately 36% of the drug is absorbed, and it undergoes extensive first-pass metabolism. This results in the formation of active metabolites that contribute to its efficacy. The half-life ranges between 7 to 12 hours, allowing for a twice-daily dosing strategy that maintains effective therapeutic levels in the bloodstream.

Benefits for athletic performance, endurance and recovery

Athletes continually seek ways to enhance performance, maximize endurance, and improve recovery. BRILINTA may offer some benefits in these areas due to its effect on blood flow and oxygen delivery to tissues. By preventing platelet aggregation, the medication can theoretically allow for better microcirculation and improved oxygen transport during intense physical activities. This may lead to enhanced endurance, particularly in sports requiring prolonged exertion.

Moreover, the anti-inflammatory properties associated with BRILINTA may aid in recovery following strenuous workouts. Reduced inflammation can lead to quicker recovery times, allowing athletes to train more frequently without the accompanying fatigue or muscle soreness. The potential for improved circulation may also expedite the removal of metabolic waste products such as lactic acid, further contributing to recovery efficiency.

However, while some athletes may consider these benefits, it is crucial to approach the use of BRILINTA with caution, paying close attention to each individual’s medical history and the potential impact on athletic performance.

Buy BRILINTA 90 MG AstraZeneca on our website, fast, secure, and verified

Purchasing BRILINTA 90 MG AstraZeneca through our website is designed to be a straightforward and secure process. Our platform prioritizes user safety and confidentiality, ensuring that every order is handled with the utmost diligence.

We offer fast shipping options so you can receive your medication promptly. The website also features customer support services to help with any inquiries related to your purchase, such as dosage questions or concerns about interaction with other medications. Take advantage of our verified platform to make informed purchasing decisions.

Contraindications, precautions for use

While BRILINTA demonstrates various potential advantages, it is not suitable for everyone. Key contraindications include individuals who have a history of bleeding disorders, active bleeding or recent surgeries. Patients with severe liver conditions should also avoid using this medication.

Those taking specific medications, including strong CYP3A4 inhibitors like ketoconazole, should exercise caution. Combination with these drugs may increase the risk of adverse events. Additionally, pregnant or breastfeeding women should consult healthcare professionals before use. Allergic reactions to ticagrelor or any excipients in BRILINTA should be taken seriously, necessitating immediate discontinuation of the medication.

Dosage guide

BRILINTA is typically prescribed at a dose of 90 mg taken twice daily, usually in conjunction with aspirin. This dual therapy aims to maximize its antiplatelet effects. For patients switching from another antiplatelet medication, the doctor will provide specific guidance on when to initiate BRILINTA.

Adherence to the prescribed dosage is essential for maintaining its efficacy and minimizing risks. Should any side effects or unusual symptoms arise, it is critical to contact a healthcare professional immediately for advice. Individual healthcare providers may adjust the dosage based on patient-specific factors, so ongoing monitoring and communication are vital for optimal treatment outcomes.

• BRILINTA requires a prescription and is not available over-the-counter.
• Consult with a healthcare provider before using for athletic purposes.
• Long-term commitment to healthcare guidance enhances safety and effectiveness.
• Stay informed about updates regarding dosage and medical guidelines.